National Academies Press: OpenBook

Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals (2001)

Chapter: I Example of the AEGL Derivation Summary Appendix in a Technical Support Document

« Previous: H Example of a Carcinogenicity Assessment Appendix in a Technical Support Document
Suggested Citation:"I Example of the AEGL Derivation Summary Appendix in a Technical Support Document." National Research Council. 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: The National Academies Press. doi: 10.17226/10122.
×

Appendix I
Example of the AEGL Derivation Summary Appendix in A Technical Support Document

DERIVATION SUMMARY FOR ACUTE EXPOSURE GUIDELINE LEVELS FOR DIMETHYLHYDRAZINE

(CAS No. 57–14–7; 1,1-Dimethylhydrazine)

(CAS No. 540–73–8; 1,2-Dimethylhydrazine)

AEGL-1 Values

30 min

1 h

4 h

8 h

Not recommended

Not recommended

Not recommended

Not recommended

Reference: Not applicable

Test Species/Strain/Number: Not applicable

Exposure Route/Concentrations/Durations: Not applicable

Effects: Not applicable

Endpoint/Concentration/Rationale: Not applicable

Suggested Citation:"I Example of the AEGL Derivation Summary Appendix in a Technical Support Document." National Research Council. 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: The National Academies Press. doi: 10.17226/10122.
×

Uncertainty Factors/Rationale: Not applicable

Modifying Factor: Not applicable

Animal to Human Dosimetric Adjustment: Not applicable

Time Scaling: Not applicable

Data Adequacy: Numeric values for AEGL-1 are not recommended because (1) data are not available, (2) data indicate that toxic effects may occur at or below the odor threshold, (3) an inadequate margin of safety exists between the derived AEGL-1 and the AEGL-2, or (4) the derived AEGL-1 is greater than the AEGL-2. Absence of an AEGL-1 does not imply that exposure below the AEGL-2 is safe.

NOTE: If an AEGL-1 value is not recommended, there should be a short discussion of the rationale for that choice. The rationale should include as appropriate a discussion that numeric values for AEGL-1 are not recommended because (1) relevant data are lacking, (2) the margin of safety between the derived AEGL-1 and AEGL-2 values is inadequate, or (3) the derived AEGL-1 is greater than the AEGL-2. Absence of an AEGL-1 does not imply that exposure below the AEGL-2 is safe.

AEGL-2 Values

30 min

1 h

4 h

8 h

6.0 ppm

3.0 ppm

0.75 ppm

0.38 ppm

Reference: Weeks, M.H., G.C.Maxey, M.E.Sicks, and E.A.Greene. 1963. Vapor toxicity on UDMH in rats and dogs from short exposures. Am. Ind. Hyg. Assoc. J. 24:137–143

Test Species/Strain/Sex/Number: mongrel dogs, 2–4/group, sex not specified

Exposure Route/Concentrations/Durations: Inhalation; 1,200–4,230 ppm for 5 min; 360, 400, or 1,530 ppm for 15 min; 80–250 ppm for 60 min

Effects:

Exposure (15 min)

Effect

360 ppm

muscle fasciculations in 1 of 4 dogs (determinant for AEGL-2)

400 ppm

behavioral changes in 2 of 4 dogs

1,530 ppm

tremors, convulsions, vomiting in 2 of 2 dogs

Endpoint/Concentration/Rationale: 15-min exposure at 360 ppm considered a threshold for potentially irreversible effects or effects that would impair escape. At this exposure, muscle fasciculations were observed in 1 of 4 exposed dogs, and at 400 ppm, behavioral changes were observed.

Suggested Citation:"I Example of the AEGL Derivation Summary Appendix in a Technical Support Document." National Research Council. 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: The National Academies Press. doi: 10.17226/10122.
×

Uncertainty Factors/Rationale: Total uncertainty factor: 30

Interspecies: 3—The toxic response to dimethylhydrazine (LC50 values) was similar across species. The 4-h LC50 values for mouse, rat, and hamster differ by a factor of approximately 2 and were consistent with the dog data when extrapolated from 1 h using n=1. The more susceptible species, the dog, was used to derive the AEGL-2 values.

Intraspecies: 10—A broad spectrum of effects were seen, including behavioral effects, hyperactivity, fasciculations, tremors, convulsions, and vomiting. The mechanism of toxicity is uncertain and susceptibility among individuals regarding these effects may vary. This variability was especially demonstrated in dogs wherein responses varied from one of extreme severity (vomiting, tremors, convulsions, and death) to no observable effects. Therefore, a factor of 10 was applied. A factor of 10 was also applied because experiments by Weeks et al. (1963) indicated that dogs had been previously stressed (auditory stimuli), which may have affected their response to dimethylhydrazine. Based upon these data, it was assumed that humans may be equally variable in their response to dimethylhydrazine.

Modifying Factor: None

Animal to Human Dosimetric Adjustment: None applied, insufficient data

Time Scaling: Cn×t=k, where n=1 and k=180 ppm·min; LC50 data were available for 5-, 15-, 30-, 60-, and 240-min exposures in rats and 5-, 15-, and 60-min in dogs. Exposure-response data indicated a near linear concentration-response relationship (n=0.84 for rats; n=0.80 for dogs). For time-scaling, a linear relationship was assumed and a value where n=1 was selected.

Data Adequacy: Information regarding the human experience for acute inhalation exposure to dimethylhydrazine are limited to qualitatively case reports indicating nasal and respiratory tract irritation, breathing difficulties, and nausea. Data in animals have shown concentration-dependent effects ranging from respiratory tract irritation, pulmonary edema and neurologic effects to lethality. Because the nonlethal effects in humans and animals are qualitatively similar, the animal data were considered relevant and appropriate for development of AEGL values. The AEGL values for dimethylhydrazine reflect the steep exposure-response relationship suggested by available data.

Suggested Citation:"I Example of the AEGL Derivation Summary Appendix in a Technical Support Document." National Research Council. 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: The National Academies Press. doi: 10.17226/10122.
×

AEGL-3 Values

30 min

1 h

4 h

8 h

22 ppm

11 ppm

2.7 ppm

1.4 ppm

Reference: Weeks, M.H., G.C.Maxey, M.E.Sicks, and E.A.Greene. 1963. Vapor toxicity of UDMH in rats and dogs from short exposures. Am. Ind. Hyg. Assoc. J. 24:137–143

Test Species/Strain/Sex/Number: mongrel dogs, 3–4/group; sex not specified

Exposure Route/Concentrations/Durations: Inhalation; exposure to various concentrations (80–22,300 ppm) for 5, 15, or 60 min

Effects:

1-h LC50

981 ppm (reduction by 1/3 was basis for AEGL-3 derivation)

15-min LC50

3,580 ppm

5-min LC50

22,300 ppm

Endpoint/Concentration/Rationale: 1-h LC50 (981 ppm) reduced by 1/3 was considered an estimate of the lethality threshold (327 ppm). Based on the available exposure-response data for this chemical (Jacobson et al. 1955), a 3-fold reduction in LC50 values results in exposures that would not be associated with lethality.

Uncertainty Factors/Rationale: Total uncertainty factor: 30

Interspecies: 3—The toxic response to dimethylhydrazine (LC50 values) was similar across species. The 4-h LC50 values for mouse, rat, and hamster differ by a factor of approximately 2 and were consistent with the dog data when extrapolated from 1 h using n=1. The more susceptible species, the dog, was used to derive the AEGL-3 values.

Intraspecies: 10—A broad spectrum of effects were seen, including behavioral effects, hyperactivity, fasciculations, tremors, convulsions, and vomiting. The mechanism of toxicity is uncertain, and susceptibility among individuals regarding these effects may vary. This variability was especially demonstrated in dogs wherein responses varied from one of extreme severity (vomiting, tremors, convulsions, and death) to no observable effects. Therefore, a factor of 10 was used. A factor of 10-fold was also used because experiments by Weeks et al. (1963) indicated that dogs previously stressed by auditory stimuli may have a potentiated response to dimethylhydrazine. Based upon these data, it was assumed that humans may be equally variable in their response to dimethylhydrazine subsequent to similar stresses.

Modifying Factor: None

Animal to Human Dosimetric Adjustment: None applied, insufficient data

Suggested Citation:"I Example of the AEGL Derivation Summary Appendix in a Technical Support Document." National Research Council. 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: The National Academies Press. doi: 10.17226/10122.
×

Time Scaling: Cn×t=k, where n=1 and k=654 ppm·min; LC50 data were available for 5-, 15-, 30-, 60-, and 240-min exposures in rats and 5-, 15-, and 60-min in dogs. Exposure-response data indicated a near linear concentration-response relationship (n=0.84 for rats; n=0.80 for dogs). For time-scaling, a linear relationship was assumed and a value where n=1 was selected by the National Advisory Committee.

Data Adequacy: Information regarding the lethality of dimethylhydrazine in humans were not available. Lethality data for several animal species allowed for a defensible development of the AEGL-3 values but uncertainties remain regarding individual variability in the toxic response to dimethylhydrazines.

Suggested Citation:"I Example of the AEGL Derivation Summary Appendix in a Technical Support Document." National Research Council. 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: The National Academies Press. doi: 10.17226/10122.
×
Page 196
Suggested Citation:"I Example of the AEGL Derivation Summary Appendix in a Technical Support Document." National Research Council. 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: The National Academies Press. doi: 10.17226/10122.
×
Page 197
Suggested Citation:"I Example of the AEGL Derivation Summary Appendix in a Technical Support Document." National Research Council. 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: The National Academies Press. doi: 10.17226/10122.
×
Page 198
Suggested Citation:"I Example of the AEGL Derivation Summary Appendix in a Technical Support Document." National Research Council. 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: The National Academies Press. doi: 10.17226/10122.
×
Page 199
Suggested Citation:"I Example of the AEGL Derivation Summary Appendix in a Technical Support Document." National Research Council. 2001. Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals. Washington, DC: The National Academies Press. doi: 10.17226/10122.
×
Page 200
Next: J List of Extant Standards and Guidelines in a Technical Support Document »
Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals Get This Book
×
Buy Paperback | $55.00 Buy Ebook | $43.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals contains a detailed and comprehensive methodology for developing acute exposure guideline levels (AEGLs) for toxic substances from inhalation exposures.

The book provides guidance on what documents and databases to use, toxicity endpoints that need to be evaluated, dosimetry corrections from animal to human exposures, selection of appropriate uncertainty factors to address the variability between animals and humans and within the human population, selection of modifying factors to address data deficiencies, time scaling, and quantitative cancer risk assessment.

It also contains an example of a summary of a technical support document and an example of AEGL derivation. This book will be useful to persons in the derivation of levels from other exposure routes—both oral and dermal—as well as risk assessors in the government, academe, and private industry.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!